Key Takeaways
- •Pinealon consists of the synthetic tripeptide sequence Glu-Asp-Arg, denoted as EDR in single-letter code.
- •Studies by Khavinson and colleagues revealed that EDR, or Pinealon, promotes neuronal cell growth and lowers apoptosis indicators in cortical neuron cultures.
- •Linkova and others reported that EDR exposure modified PCNA (proliferating cell nuclear antigen) and p21 expression in n
Pinealon: Neuroprotective Tripeptide Research Guide
Pinealon consists of the synthetic tripeptide sequence Glu-Asp-Arg, denoted as EDR in single-letter code. Researchers at the St. Petersburg Institute of Bioregulation and Gerontology, led by Vladimir Khavinson, created it as part of peptide bioregulators that influence gene expression in targeted tissues. This compound focuses on the central nervous system, based on findings of natural di- and tripeptides in the pineal gland and CNS neurons that affect neuroprotection-related genes.
Key Research Findings
Studies by Khavinson and colleagues revealed that EDR, or Pinealon, promotes neuronal cell growth and lowers apoptosis indicators in cortical neuron cultures. These outcomes link to changes in gene expression for DNA repair and antioxidant systems (PMID 23199282). In rats facing hypoxia-induced neuron damage, prior treatment with Pinealon decreased oxidative stress signs and maintained mitochondrial membrane stability versus controls.
Linkova and others reported that EDR exposure modified PCNA (proliferating cell nuclear antigen) and p21 expression in neuronal cultures, pointing to influences on cell cycle control for neuroregeneration studies (PMID 27262825).
Khavinson's Peptide Bioregulator Approach
Vladimir Khavinson has authored hundreds of papers over decades on short peptides from specific tissues that regulate gene activity in matching organs. His team at the St. Petersburg Institute developed synthetic versions like Epithalon for pineal gland, Pinealon for CNS, Cortagen for cortex, Vesugen for blood vessels, and more.
These tripeptides supposedly function as chromatin regulators by entering nuclei and adjusting histone binding to gene promoters. Publications include electron microscopy, fluorescence data on nuclear presence, and transcriptomic analyses of gene shifts post-treatment. Note that most work originates from this single group with little independent verification in Western literature, which affects how to evaluate the results.
Gene Expression and Neuroprotection in Cell Studies
Research on Pinealon in stressed neuronal cultures provides strong evidence. In 2012, Khavinson et al. (PMID 23199282) tested EDR on rat cerebral cortex neurons under hydrogen peroxide oxidative stress. Treated cells had less caspase-3 activity, fewer reactive oxygen species than stressed untreated ones, and stable mitochondrial potential. Antioxidant genes like Sod2 (manganese superoxide dismutase) and Cat (catalase) saw increased activity.
Linkova et al. in 2016 (PMID 27262825) observed EDR boosting PCNA while adjusting p21 in neural progenitor cells, aligning with enhanced proliferation. This suggests Pinealon could aid neuronal replacement in CNS repair, but cell culture results differ greatly from proven in vivo neuron generation. For precise definitions of terms like PCNA, consult the Peptide Glossary.
Performance in Hypoxia and Ischemia Models
Khavinson's publications cover Pinealon in rat cerebral ischemia and hypoxia setups. Pretreated animals in transient global ischemia models displayed reduced infarct sizes and improved spatial memory in Morris water maze tests compared to controls. Brain sections showed less neuron death in the vulnerable CA1 hippocampal area.
Mechanisms span reduced lipid peroxidation, fewer pro-inflammatory cytokines, and sustained anti-apoptotic Bcl-2 proteins. Questions remain if these stem directly from gene changes or follow as secondary effects, yet the broad protection appears in multiple group papers. Most designs involved pretreatment before injury, limiting direct clinical comparisons since post-injury use proves harder to show.
Pinealon in Aging Brain Models
Khavinson's team views Pinealon as part of anti-aging peptides with Epithalon. In 24-month-old Wistar rats, treatment normalized cortical and hippocampal neuron activity markers to youthful levels, including acetylcholine synthesis enzymes, synaptic proteins, and dendritic spine counts.
Lifespan extension claims in rodents demand strict methods and large groups, and some Khavinson data face methodological critiques. For CNS studies, stick to in vitro and acute in vivo measures over longevity assertions. Tools like the Half-Life Calculator can assist with experimental planning.
Molecular Structure and Brain Access
Pinealon's tripeptide size allows potential blood-brain barrier crossing via passive diffusion, unlike bigger peptides needing special delivery. Khavinson studies with radiolabeled EDR confirmed CNS accumulation after rodent systemic dosing.
Short peptide barrier passage seems feasible, but independent pharmacokinetic validation would help. In vitro, nuclear entry claims for gene modulation are straightforward to test without delivery issues.
In summary, Pinealon research emphasizes neuroprotection through gene regulation, antioxidant boosts, and repair in stress models. Data merits attention despite group origin, guiding CNS preclinical work. Explore our free peptide tools for research support.